Effect for sodium sensitivity of blood pressure of empagliflozin, sodium-glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000026537
- Lead Sponsor
- Osaka City General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
advanced liver disorder. easy to be dehydrated. have hypertension, more than 180/110mmHg, or attending physician judged poor control of hypertension.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method